Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B? Odds jumped to 97% on Jul 15, 2026

Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B? On Jul 15, 2026, 10:20 UTC, the market’s odds jumped from 73.5¢ to 96.6¢ (+23.1 pts) within an hour of an AI-matched news signal from News. The market has since resolved Yes.

How did the odds move?

Yes-side prices at the moment the news was matched and at the stamped impact windows after it. Windows the tracker could not measure inside its honesty band are omitted, never estimated.

Later moves the same day

This is the market’s single brief for Jul 15, 2026; further measured moves that day are folded in here as they are stamped.

• Jul 15, 2026, 10:27 UTC73.5¢ → 96.6¢+23.1 ptsafter a signal from livesquawk

What moved the odds?

Where does this market stand now?

This market has resolved Yes. Final market pricing put YES at 100%, as of Aug 30, 2026, 15:54 UTC.

Vol$5K

Follow this market

Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B? — live odds, order flow, and the full signal timeline.

See all outcomes for Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above __? — the full event, with combined odds and signal timeline.